Attila Kiss

34PUBLICATIONS
140CO-AUTHORS
Predictive and prognostic markersGlycoconjugatesCardiology (incl. cardiovascular diseases)Electrical energy generation (incl. renewables, excl. photovoltaics)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 28, 2026
Longitudinal [18F]FDG PET/MR Assessment of Arterial Inflammation in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy.

|Mar 28, 2026
Vasculoprotective Effects of Sodium-Glucose Co-Transporter Inhibitors in Non-Diabetic Experimental Settings: A Narrative Review.

Darius G Buriman, Lavinia Noveanu, Adina V Furdui-Lința

|Mar 16, 2026
The prognostic value of systemic inflammatory response index (SIRI) in acute coronary syndrome patients treated with primary percutaneous coronary intervention: a meta-analysis and systematic review.

Chenming Hu, Qianling Ye, Shunjie You

|Aug 12, 2025
The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels.

Jakob Sauer, Jessica Marksteiner, Martin Hohenegger

|Aug 11, 2025
Inhibition of tenascin C rescues abnormally reduced Na currents in dystrophin-deficient ventricular cardiomyocytes.

Jessica Marksteiner, Jakob Sauer, Martin Hohenegger

|Jan 25, 2025
Characterizing SV40-hTERT Immortalized Human Lung Microvascular Endothelial Cells as Model System for Mechanical Stretch-Induced Lung Injury.

Beatrix Hochreiter, Claudia Lindner, Matthias Postl

Pageof 6

Frequent Collaborators

22 joint publications

Bruno Karl Podesser

6 joint publications

Stefan Heber

4 joint publications

Petra Lujza Szabó

4 joint publications

Michael J M Fischer